The incidence of Type 2 diabetes is increasing globally at a dramatic rate. Sufferers are twice as likely to develop cardiovascular disease or have a stroke, and the long term health complications can be serious and debilitating.
The cost of managing and treating this disease and its many complications are staggering and many of the currently approved therapies are inadequate, resulting in unmet needs and insufficient treatment.
Providing an overview of the most recent advances in small molecule discovery, New Therapeutic Strategies for Type 2 Diabetes, edited by Robert M Jones and published in the RSC Drug Discovery series, will enable readers to understand the trials and tribulations of developing new oral medications aimed at the treatment of this global epidemic.
Each chapter is written by a recognised expert and explains the biological mechanism underpinning each of the medicinal chemistry strategies highlighted. New Therapeutic Strategies for Type 2 Diabetes will provide both biologists and medicinal chemists with a key text on this important medicinal and economic issue.
Find out how chemists are tackling this global killer here.
